InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (9 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
9
T+90 hit rate
100%
T+90 mean return
+40.2%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Coleman Mark, Director. Insider active across 1 company, notably Axsome Therapeutics, Inc.. Aggregated, 23 reports have been logged. Breakdown: 5 buys · 9 sells. Total volume traded: €8.4m. Activity tracked since 12 May 2021. The latest transaction was disclosed on 2 June 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Coleman Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
1,429 sharesCommon StockSEC:0001193125-26-266433:0
643 sharesCommon StockSEC:0001193125-26-266433:1
6,000 shares@ US$233.460.013% mcap25.6% of flowCommon StockSEC:0001193125-26-254038:0
6,000 shares@ US$230.300.013% mcap25.2% of flowCommon StockSEC:0001193125-26-254038:1
5,537 shares@ US$223.390.011% mcap22.6% of flowCommon StockSEC:0001193125-26-254038:2
25,000 shares@ US$161.1141.7% of flowCommon StockSEC:0001193125-26-083587:0
6,250 shares@ US$4.950.3% of flowCommon StockSEC:0001193125-26-072481:0
12,485 shares@ US$4.950.6% of flowCommon StockSEC:0001193125-26-064681:0
5,193 shares@ US$8.020.7% of flowCommon StockSEC:0001193125-26-045110:0
800 shares@ US$127.201.8% of flowCommon StockSEC:0000950170-25-113874:0
Canonical exit: 7 Dec 2025 (T+90)
287 shares@ US$127.300.7% of flowCommon StockSEC:0000950170-25-113874:1
Canonical exit: 7 Dec 2025 (T+90)
488 shares@ US$127.401.1% of flowCommon StockSEC:0000950170-25-113874:2
Canonical exit: 7 Dec 2025 (T+90)
3,750 shares@ US$105.473.9% of flowCommon StockSEC:0000950170-25-079229:0
3,750 shares@ US$103.433.9% of flowCommon StockSEC:0000950170-25-079229:1
3,000 shares@ US$107.4916.1% of flowCommon StockSEC:0000950170-25-075539:0
9,127 shares@ US$9.001.7% of flowCommon StockSEC:0000950170-25-002052:0
33,410 shares@ US$5.944.0% of flowCommon StockSEC:0000950170-24-129330:0
5,249 shares@ US$75.20957.7% of flowCommon StockSEC:0000950170-24-066175:0
11,016 shares@ US$3.6727.8% of flowCommon StockSEC:0001209191-23-049648:0
17,501 shares@ US$1.300.5% of flowCommon StockSEC:0001209191-23-000870:0
3,496 shares@ US$1.300.0000% mcap5.3% of flowCommon StockSEC:0001209191-22-019403:0
409 shares@ US$35.070.1% of flowCommon StockSEC:0001209191-21-066004:0
Canonical exit: 16 Feb 2022 (T+90)
500 shares@ US$58.150.2% of flowCommon StockSEC:0001209191-21-032250:0
Canonical exit: 10 Aug 2021 (T+90)
23 of 23 declarations
About Coleman Mark
Coleman Mark is Administrateur at Axsome Therapeutics, Inc. He has filed 23 filings in total, and across the recent filings sample available, buys amount to EUR 207074 and sells to EUR 8213328 between 2021-05-13 and 2026-06-10. The most frequent transaction nature is Levée d'options.
